NCT01717859View on ClinicalTrials.gov

Musculoskeletal Ultrasound in Predicting Early Dose Titration With Tocilizumab

PHASE4CompletedINTERVENTIONAL

Enrollment

74

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Tocilizumab

All subjects will start at 4mg/kg. After 3 months, if DAS28 \> 3.2, dosage will be escalated to 8 mg/kg.

Trial Locations (1)

90095

UCLA David Geffen School of Medicine, Division of Rheumatology, Los Angeles

Sponsors

Collaborators (1)

Genentech, Inc.

All Listed Sponsors

collaborator

Genentech, Inc.

INDUSTRY

lead

University of California, Los Angeles

OTHER